Hugel Inc 145020
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- ₩245,000.00
- Day Range
- ₩237,500.00–249,500.00
- 52-Week Range
- —–—
- Bid/Ask
- ₩239,000.00 / ₩239,500.00
- Market Cap
- —
- Volume/Avg
- 55,824 / 76,727
Key Statistics
- Price/Earnings (Normalized)
- 21.37
- Price/Sales
- 8.42
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 6.69%
Company Profile
Hugel Inc is a biopharmaceutical company. It is in the business of manufacturing of biopharmaceuticals. The company's primary products are Botulinum toxin, Hyaluronic acid filler, and Cosmetics. It develops and promotes its products under the brand name of Wellage. The firm has manufacturing facilities in Shinbuk and Geodu.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 631
- Website
- http://www.hugel.co.kr
Comparables
Valuation
|
Metric
|
145020
|
216080
|
174900
|
|---|---|---|---|
Price/Earnings (Normalized) | 21.37 | 167.91 | — |
Price/Book Value | 3.41 | 4.35 | 9.76 |
Price/Sales | 8.42 | 4.64 | 102.56 |
Price/Cash Flow | 20.42 | 27.60 | — |
Price/Earnings
145020
216080
174900
Financial Strength
|
Metric
|
145020
|
216080
|
174900
|
|---|---|---|---|
Quick Ratio | 9.71 | 0.25 | 1.05 |
Current Ratio | 10.74 | 0.42 | 1.22 |
Interest Coverage | 57.61 | 1.41 | −14.04 |
Quick Ratio
145020
216080
174900
Profitability
|
Metric
|
145020
|
216080
|
174900
|
|---|---|---|---|
Return on Assets (Normalized) | 14.12% | 2.09% | −39.00% |
Return on Equity (Normalized) | 17.79% | 7.45% | −63.66% |
Return on Invested Capital (Normalized) | 14.09% | 8.17% | −42.13% |
Return on Assets
145020
216080
174900
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Tsrcpvnrw | Wfhw | $531.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Kwmykncd | Fmyzd | $119.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Ltybmdkr | Vzlwprg | $114.9 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Vclrtcjjq | Njzhfkn | $35.3 Bil | |||
| argenx SE ADR
ARGX
| Rkncrwpyw | Qxbr | $32.0 Bil | |||
| BioNTech SE ADR
BNTX
| Tnplcjtv | Qxdx | $28.1 Bil | |||
| Moderna Inc
MRNA
| Lsjwxmng | Rtd | $25.3 Bil | |||
| United Therapeutics Corp
UTHR
| Qnvmwjrl | Bnkx | $16.0 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Grslzgg | Dmlps | $13.4 Bil | |||
| Incyte Corp
INCY
| Nykwgvsfh | Llmbxd | $12.7 Bil |
United States